LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Banerji, A.
Hao, J.
Yu, M.
Bernstein, J.
Johnston, D.
Riedl, M.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2020年 / 125卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P150
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [41] Long-term efficacy and safety of mirikizumab treatment for Crohn's Disease: Results from the VIVID-2 open-label extension study
    Vermeire, S.
    Sands, B. E.
    D'Haens, G.
    Hisamatsu, T.
    Kelly, C. R.
    Lu, N.
    Morris, N.
    Moses, R.
    Durand, F.
    Protic, M.
    Hozak, R. R.
    Lopes, M. U.
    Regueiro, M.
    Laharie, D.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i87 - i89
  • [42] Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to-Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study
    Wallace, D. J.
    Hobbs, K.
    Clowse, M. E. B.
    Petri, M.
    Strand, V.
    Pike, M.
    Merrill, J. T.
    Leszczynski, P.
    Neuwelt, C. M.
    Jeka, S.
    Houssiau, F.
    Keiserman, M.
    Ordi-Ros, J.
    Bongardt, S.
    Kilgallen, B.
    Galateanu, C.
    Kalunian, K.
    Furie, R.
    Gordon, C.
    ARTHRITIS CARE & RESEARCH, 2016, 68 (04) : 534 - 543
  • [43] Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, W. Rachel
    Pang, Yinuo
    Lee, Wan-Ju
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (12) : 2001 - 2010
  • [44] Long-term efficacy and safery of switching from Ustekinumab to Risankizuman: results from the open-label extension LIMMitless
    Strober, Bruce
    Eyerich, Killian
    Hong, H. Chih-Ho
    Zeng, Jiewei
    Valdecantos, Wendell C.
    Valdes, Joaquin
    Bachelez, Herve
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 19 - 19
  • [45] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [46] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
    Wroe, S
    Brodie, MJ
    EPILEPSIA, 2005, 46 : 118 - 118
  • [47] Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: An open-label extension trial
    McConville, B
    Carrero, L
    Sweitzer, D
    Potter, L
    Chaney, R
    Foster, K
    Sorter, M
    Friedman, L
    Browne, K
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) : 75 - 82
  • [48] Sparsentan for Focal Segmental Glomerulosclerosis in the DUET Open-Label Extension: Long-term Efficacy and Safety
    Campbell, Kirk N.
    Gesualdo, Loreto
    Murphy, Edward
    Rheault, Michelle N.
    Srivastava, Tarak
    Tesar, Vladimir
    Komers, Radko
    Trachtman, Howard
    KIDNEY MEDICINE, 2024, 6 (06)
  • [49] Long-term safety and efficacy of lanreotide treatment in Japanese patients with neuroendocrine tumors: Final analysis of a phase II open-label extension study
    Ito, Tetsuhide
    Hisamatsu, Seiichi
    Nakajima, Akihiro
    Shimatsu, Akira
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [50] Long-term efficacy/safety of adjunctive eslicarbazepine acetate:open-label extension study in adults with focal seizure
    Biraben, A.
    Grinnell, T.
    Pereira, A.
    Ikedo, F.
    Moreira, J.
    Gama, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 480 - 480
12345